Institutional Ownership Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO). We have compiled data on the 272 institutions that hold shares in the stock, with a total of 86 Million shares, which have been reported (via 13F filing form) to have a value of $4.46 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
260,601
shares
|
$13.5 Million
0.0% of portfolio
|
Q1 2025
Added 293.28%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Apr 28, 2025 Q1 2025 |
257,025
shares
|
$13.3 Million
0.01% of portfolio
|
Q1 2025
New holding
|
|
|
Ikarian Capital, LLC
Dallas, TX |
May 15, 2025 Q1 2025 |
245,000
shares
|
$12.7 Million
1.39% of portfolio
|
Q1 2025
New holding
|
|
|
B Group, Inc.
Dallas, TX |
May 15, 2025 Q1 2025 |
242,500
shares
|
$12.6 Million
8.41% of portfolio
|
Q1 2025
Reduced 6.73%
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
234,172
shares
|
$12.1 Million
0.0% of portfolio
|
Q1 2025
Added 166.36%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
234,130
shares
|
$12.1 Million
0.0% of portfolio
|
Q4 2024
Added 16.95%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
230,864
shares
|
$12 Million
0.01% of portfolio
|
Q1 2025
Added 1279.45%
|
|
|
Propel Bio Management, LLC
Los Angeles, CA |
May 15, 2025 Q1 2025 |
228,884
shares
|
$11.9 Million
10.76% of portfolio
|
Q1 2025
Reduced 33.41%
|
|
|
Eagle Health Investments LP
Greenwich, CT |
May 12, 2025 Q1 2025 |
226,400
shares
|
$11.7 Million
2.38% of portfolio
|
Q1 2025
New holding
|
|
|
Td Asset Management Inc
|
May 07, 2025 Q1 2025 |
208,848
shares
|
$10.8 Million
0.01% of portfolio
|
Q1 2025
Added 23.1%
|
|
|
Emerald Mutual Fund Advisers Trust
|
May 01, 2025 Q1 2025 |
207,035
shares
|
$10.7 Million
0.68% of portfolio
|
Q1 2025
Reduced 41.21%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
May 12, 2025 Q1 2025 |
201,168
shares
|
$10.4 Million
2.21% of portfolio
|
Q1 2025
New holding
|
|
|
Eventide Asset Management, LLC
Boston, MA |
May 15, 2025 Q1 2025 |
200,534
shares
|
$10.4 Million
0.17% of portfolio
|
Q1 2025
New holding
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
199,000
shares
|
$10.3 Million
0.01% of portfolio
|
Q1 2025
Added 856.73%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2025 Q1 2025 |
195,000
shares
|
$10.1 Million
0.02% of portfolio
|
Q1 2025
New holding
|
|
|
Jane Street Group, LLC
New York, NY |
May 19, 2025 Q1 2025 |
182,457
shares
|
$9.47 Million
0.0% of portfolio
|
Q1 2025
Reduced 18.91%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
180,390
shares
|
$9.36 Million
0.0% of portfolio
|
Q1 2025
Added 411.48%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
179,900
shares
|
$9.33 Million
0.23% of portfolio
|
Q1 2025
Added 172.58%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
May 15, 2025 Q1 2025 |
174,960
shares
|
$9.08 Million
0.05% of portfolio
|
Q1 2025
Added 479.18%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
171,518
shares
|
$8.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.94%
|
|
|
Russell Investments Group, Ltd.
|
May 13, 2025 Q1 2025 |
158,275
shares
|
$8.21 Million
0.01% of portfolio
|
Q1 2025
Added 7613.21%
|
|
|
Stem Point Capital LP
New York, NY |
May 15, 2025 Q1 2025 |
156,185
shares
|
$8.1 Million
2.02% of portfolio
|
Q1 2025
New holding
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
May 14, 2025 Q1 2025 |
155,044
shares
|
$8.04 Million
0.01% of portfolio
|
Q3 2024
Reduced 34.72%
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
May 15, 2025 Q1 2025 |
151,290
shares
|
$7.85 Million
0.01% of portfolio
|
Q1 2025
Added 21.43%
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
150,142
shares
|
$7.79 Million
0.01% of portfolio
|
Q1 2025
Added 1767.44%
|